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Introduction: The development of water-soluble polymers such as PEI-MP (polyethyleneimine, 
functionalised with methylphosphonate groups) that might be labeled with 188Re (emits of high 
energy beta particles) and 99mTc are recent approaches, with a strong potential for metabolic 
radiotherapy and diagnosis, respectively. The aim of this study was to evaluate the efficacy of 
188Re-PEI-MP as therapeutic agent for bladder carcinoma and 99mTc-PEI-MP for its diagnosis and 
follow up.  
Material and Method: Cytotoxicity of PEI-MP was investigated in bladder carcinoma cell line 
(CRL-1472) using the MTT test for different concentrations of PEI-MP (1 µM to 1000 µM) and 
incubation times (24h, 48h, 72h and 96h). Radiochemical purity of 188Re-PEI-MP and 99mTc-PEI-
MP was achieved using ascending microchromatography. Cellular uptake studies were 
performed with CRL-1472 cell line. 188Re-PEI-MP, 99mTc-PEI-MP, Na188ReO4 or Na99mTcO4 were 
added to cell suspension (2 million cells/mL). Cell samples were collected during four hours, 
centrifuged to separate supernatant and pellet. Subsequently, the radioactivity of each portion 
 
  
  
  
 
 
 
 
 
was counted to determine percentage of uptake. The in vivo studies were performed using six 
groups of Balb/c nu/nu mice: four normal groups injected with Na188ReO4 (n=18), 188Re-PEI-MP 
(n=17), Na99mTcO4 (n=10) and 99mTc-PEI-MP (n=10), respectively; two with bladder carcinoma 
xenotransplants injected with Na188ReO4 (n=8) and 188Re-PEI-MP (n=12), respectively. When 
tumor reached the appropriate volume, Na188ReO4, 188Re-PEI-MP, Na99mTcO4 or 99mTc-PEI-MP, 
were administered by an intravenous injection in the tail vein (22-37MBq), with the animal 
anesthetized and previously placed on the gamma camera detector. Immediately, a dynamic 
acquisition followed, with a 128x128 matrix for 10 min (20 frames, 30 seconds). Static images (2 
min) were performed with a 256x256 matrix, where each of the six groups was divided into two 
groups, of which one was imaged at 120 minutes, and the other at 240 minutes. For 
biodistribution proposes, mice were euthanized 2 and 4 hours after injection and organ samples 
where weighted and counted in a well-counter to obtain percentage injected activity per gram of 
organ (%ID/g).  
Results and Discussion: The MTT assay showed that PEI-MP is not cytotoxic. The 
radiochemical purity of 188Re-PEI-MP and 99mTc-PEI-MP was ≥85%. In vitro results demonstrated 
that the uptake was relatively higher for 188Re-PEI-MP and 99mTc-PEI-MP than for Na188ReO4 and 
Na99mTcO4, respectively, remaining constant over time (4h). Biodistribution results, with 
Na188ReO4 and Na99mTcO4, showed a higher uptake by the thyroid, bladder and stomach, 
following a normal biodistribution. The biodistribution with 188Re-PEI-MP and 99mTc-PEI-MP 
showed that the excretion of these complexes occurs primarily through the renal system, with a 
small fraction being eliminated by the hepatobiliary system. Tumor/muscle ratio for 188Re-PEI-MP 
was greater than 1.5. 
Conclusions: Given to its biodistribution and tumor/muscle ratio, 188Re-PEI-MP seems to be 
promising in the treatment of bladder cancer. Following the same biodistribution as 188Re-PEI-
MP, 99mTc-PEI-MP seems to be optimal for diagnosis and follow up of therapy. 
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